Verastem Inc. (VSTM)
NASDAQ: VSTM
· Real-Time Price · USD
7.08
-0.38 (-5.09%)
At close: May 14, 2025, 3:59 PM
7.16
1.06%
After-hours: May 14, 2025, 07:28 PM EDT
Verastem Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Sale of COPIKTRA license and related assets Revenue | 2.6M |
| Sale of COPIKTRA license and related assets Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.78M | 12.28M | 10.21M | 10.35M | 8.63M | 7.36M | 7.4M | 7.33M | 6.11M | 6.42M | 6.51M | 5.93M | 5.66M | 5.52M | 6.71M | 6.22M | 7.09M | 20.61M | 15.44M | 19.6M | 23.73M | 22.15M | 29.3M | 26.03M | 26.2M | 25.43M | 15.81M | 9.83M | 6.8M | 5.39M | 4.42M | 4.76M | 4.91M | 3.84M | 4.22M | 4.25M | 4.27M | 4.23M | 4.42M | 4.71M |
| Selling, General, and Administrative Revenue Growth | -12.19% | +20.25% | -1.32% | +19.86% | +17.23% | -0.49% | +0.96% | +20.03% | -4.91% | -1.43% | +9.77% | +4.84% | +2.48% | -17.74% | +7.98% | -12.36% | -65.58% | +33.49% | -21.23% | -17.38% | +7.11% | -24.39% | +12.54% | -0.63% | +3.04% | +60.79% | +60.91% | +44.54% | +26.05% | +21.90% | -7.10% | -2.95% | +27.71% | -8.87% | -0.89% | -0.42% | +1.02% | -4.23% | -6.30% | n/a |
| Research and Development Revenue | 20.81M | 24.75M | 18.06M | 17.71M | 22.5M | 13.95M | 12.89M | 12.02M | 10.74M | 11.29M | 14.89M | 13.64M | 11.4M | 9.32M | 9.73M | 8.9M | 10.15M | 10.96M | 9.34M | 10.92M | 12.46M | 12.22M | 11.35M | 9.76M | 8.76M | 11.57M | 12.38M | 10.93M | 11.25M | 17.74M | 9.04M | 8.38M | 6.89M | 4.22M | 4.49M | 4.18M | 7.69M | 11.3M | 11.04M | 10.53M |
| Research and Development Revenue Growth | -15.93% | +37.05% | +2.00% | -21.31% | +61.35% | +8.17% | +7.31% | +11.87% | -4.85% | -24.18% | +9.13% | +19.71% | +22.21% | -4.16% | +9.38% | -12.38% | -7.32% | +17.24% | -14.46% | -12.30% | +1.94% | +7.69% | +16.27% | +11.37% | -24.28% | -6.54% | +13.23% | -2.83% | -36.58% | +96.23% | +7.84% | +21.66% | +63.47% | -6.14% | +7.49% | -45.64% | -31.99% | +2.34% | +4.91% | n/a |